China Pouchitis Therapeutics market size stood at around USD xx billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
Pouchitis is an inflammatory condition of the ileal pouch. It happens when the ileal pouch reservoir becomes inflamed or irritated. Pouchitis mainly occurs in a patient who has undergone ileal pouch-anal anastomosis (IPAA), a surgical procedure for removing the rectum and the large intestine. China having the highest incidence at 3.4 per 100,000 individuals.
China is a growing market for pouchitis due to factors such as rise in the incidence of pouchitis (3.4 per 100,000 individuals), increase in the number of ileal pouch-anal anastomosis procedure, long-term usage of non-steroidal anti-inflammatory drugs, increase in awareness, rise in healthcare expenditure, and growth in the geriatric population (in 2020 approximately 264 million people in China in the age group of 60 and over, amounting to some 18.70 % of the population) are the key factors driving the China pouchitis drug market.
However, there are some restraining factors for the growth of the pouchitis therapeutics market in China such as less approved products for the treatment and stringent regulations by the government.